Pierre R.
- Country
- France
- Department
- Hématologie clinique
Research Overview
Data & Insights
Has run more than one trial at 0 of 17 partner sites.
Specializations
Lymphoblastic Leukemia Research
This investigator specializes in treating acute lymphoblastic leukemia (ALL), with particular expertise in studying Philadelphia chromosome-positive variants and relapsed/refractory cases.
- CD22-positive pediatric leukemia
- High-risk relapsed ALL
- Novel immunotherapy approaches
Their work extends to young adult populations, focusing on innovative treatment protocols and survival improvement strategies.
Myeloid Malignancies
The investigator conducts research in acute myeloid leukemia (AML) and related conditions, including high-risk myelodysplastic syndrome and myeloid sarcoma.
- Stem cell transplantation protocols
- Novel conditioning regimens
- Treatment of high-risk myeloid diseases
Their expertise includes evaluating various chemotherapy combinations and targeted therapies for myeloid conditions.
Therapeutic Innovation
The investigator focuses on developing and evaluating novel therapeutic approaches for hematologic malignancies.
- Targeted antibody therapies
- Combination treatment strategies
- Risk-adapted therapeutic protocols
Their research encompasses both conventional chemotherapy optimization and innovative therapeutic agents.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.